Parkin-mediated ubiquitination regulates phospholipase C-γ1

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 3061-3068

  Dehvari, Nodi ^a   Sandebring, Anna ^a,b   Flores Morales, Amilcar ^a   Mateos, Laura ^a   Chuan, Yin Choy ^a   Goldberg, Matthew S ^c   Cookson, Mark R ^b   Cowburn, Richard F ^a,d   Cedazo Mínguez, Angel ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

Parkin; Parkinson's disease; Phospholipase C 1

Indexed keywords

PARKIN; PHOSPHOLIPASE C GAMMA; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

AGED; ANIMAL; ARTICLE; CHEMISTRY; GENE EXPRESSION REGULATION; HUMAN; MALE; METABOLISM; MOUSE; MOUSE MUTANT; MUTATION; PROTEIN TERTIARY STRUCTURE;

AGED; AGED, 80 AND OVER; ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MICE; MICE, KNOCKOUT; MUTATION; PHOSPHOLIPASE C GAMMA; PROTEIN STRUCTURE, TERTIARY; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

MURINAE; MUS;

EID: 77449124666     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00443.x     Document Type: Article

References (35)

1. Forno LS, DeLanney LE, Irwin I. Electron microscopy of Lewy bodies in the amygdala-parahippocampal region. Comparison with inclusion bodies in the MPTP-treated squirrel monkey. Adv Neurol. 1996, 69:217-28.
2. Chua CE, Tang BL. Alpha-synuclein and Parkinson's disease: the first roadblock. J Cell Mol Med. 2006, 10:837-46.
3. Hardy J, Cai H, Cookson MR. Genetics of Parkinson's disease and parkinsonism. Ann Neurol. 2006, 60:389-98.
4. Kitada T, Asakawa S, Hattori N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998, 392:605-8.
5. Shimura H, Hattori N, Kubo S. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet. 2000, 25:302-5.
6. Moore DJ, West AB, Dikeman DA. Parkin mediates the degradation-independent ubiquitination of Hsp70. J Neurochem. 2008, 105:1806-19.
7. Morett E, Bork P. A novel transactivation domain in parkin. Trends Biochem Sci. 1999, 24:229-31.
8. Sakata E, Yamaguchi Y, Kurimoto E. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep. 2003, 4:301-6.
9. Imai Y, Soda M, Takahashi R. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J Biol Chem. 2000, 275:35661-4.
10. Staropoli JF, McDermott C, Martinat C. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron. 2003, 37:735-49.
11. Corti O, Hampe C, Koutnikova H. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum Mol Genet. 2003, 12:1427-37.
12. Shimura H, Schlossmacher MG, Hattori N. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science. 2001, 293:263-9.
13. Imai Y, Soda M, Inoue H. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell. 2001, 105:891-902.
14. Huynh DP, Scoles DR, Nguyen D. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum Mol Genet. 2003, 12:2587-97.
15. Zhang Y, Gao J, Chung KK. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci USA. 2000, 97:13354-9.
16. Ko HS, Kim SW, Sriram SR. Identification of far upstream element-binding protein-1 as an authentic Parkin substrate. J Biol Chem. 2006, 281:16193-6.
17. Fallon L, Belanger CM, Corera AT. A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling. Nat Cell Biol. 2006, 8:834-42.
18. Joch M, Ase AR, Chen CX. Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels. Mol Biol Cell. 2007, 18:3105-18.
19. Ko HS, von Coelln R, Sriram SR. Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death. J Neurosci. 2005, 25:7968-78.
20. Choi P, Snyder H, Petrucelli L. SEPT5_v2 is a parkin-binding protein. Brain Res Mol Brain Res. 2003, 117:179-89.
21. Wang Y, Wu J, Wang Z. Akt binds to and phosphorylates phospholipase C-gamma1 in response to epidermal growth factor. Mol Biol Cell. 2006, 17:2267-77.
22. Tvorogov D, Carpenter G. EGF-dependent association of phospholipase C-gamma1 with c-Cbl. Exp Cell Res. 2002, 277:86-94.
23. Goldberg MS, Fleming SM, Palacino JJ. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem. 2003, 278:43628-35.
24. Cookson MR, Lockhart PJ, McLendon C. RING finger 1 mutations in Parkin produce altered localization of the protein. Hum Mol Genet. 2003, 12:2957-65.
25. Rhee SG, Bae YS. Regulation of phosphoinositide-specific phospholipase C isozymes. J Biol Chem. 1997, 272:15045-8.
26. Rhee SG. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem. 2001, 70:281-312.
27. Song C, Hu CD, Masago M. Regulation of a novel human phospholipase C, PLCepsilon, through membrane targeting by Ras. J Biol Chem. 2001, 276:2752-7.
28. Saunders CM, Larman MG, Parrington J. PLC zeta: a sperm-specific trigger of Ca(2+) oscillations in eggs and embryo development. Development. 2002, 129:3533-44.
29. Hwang JI, Oh YS, Shin KJ. Molecular cloning and characterization of a novel phospholipase C, PLC-eta. Biochem J. 2005, 389:181-6.
30. Carpenter G, Ji Q. Phospholipase C-gamma as a signal-transducing element. Exp Cell Res. 1999, 253:15-24.
31. Toker A. Signaling through protein kinase C. Front Biosci 1998, 3:D1134-47.
32. Munaron L, Antoniotti S, Lovisolo D. Intracellular calcium signals and control of cell proliferation: how many mechanisms. J Cell Mol Med. 2004, 8:161-8.
33. Verkhratsky A, Toescu EC. Neuronal-glial networks as substrate for CNS integration. J Cell Mol Med. 2006, 10:826-36.
34. Hirsch EC, Faucheux B, Damier P. Neuronal vulnerability in Parkinson's disease. J Neural Transm Suppl. 1997, 50:79-88.
35. Mouatt-Prigent A, Karlsson JO, Agid Y. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death. Neuroscience. 1996, 73:979-87.